As of 2024-12-12, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (210.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.87 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -1279.0%.
The range of the Relative Valuation is (209.15) - (238.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 42.8x | 36.6x |
| Forward P/E multiples | 20.1x - 35.8x | 26.7x |
| Fair Price | (209.15) - (238.31) | (210.68) |
| Upside | -1270.4% - -1433.6% | -1279.0% |
| Date | P/E |
| 2024-12-11 | -2.68 |
| 2024-12-10 | -2.68 |
| 2024-12-09 | -2.59 |
| 2024-12-06 | -2.62 |
| 2024-12-05 | -2.63 |
| 2024-12-04 | -2.64 |
| 2024-12-03 | -2.61 |
| 2024-12-02 | -2.64 |
| 2024-11-29 | -2.66 |
| 2024-11-27 | -2.66 |
| 2024-11-26 | -2.66 |
| 2024-11-25 | -2.58 |
| 2024-11-22 | -2.55 |
| 2024-11-21 | -2.62 |
| 2024-11-20 | -2.58 |
| 2024-11-19 | -2.56 |
| 2024-11-18 | -2.56 |
| 2024-11-15 | -2.59 |
| 2024-11-14 | -2.55 |
| 2024-11-13 | -2.56 |
| 2024-11-12 | -2.54 |
| 2024-11-11 | -2.56 |
| 2024-11-08 | -2.59 |
| 2024-11-07 | -2.59 |
| 2024-11-06 | -2.59 |
| 2024-11-05 | -2.45 |
| 2024-11-04 | -2.56 |
| 2024-11-01 | -2.48 |
| 2024-10-31 | -2.57 |
| 2024-10-30 | -3.71 |
| 2024-10-29 | -3.68 |
| 2024-10-28 | -3.70 |
| 2024-10-25 | -3.65 |
| 2024-10-24 | -3.68 |
| 2024-10-23 | -3.69 |
| 2024-10-22 | -3.71 |
| 2024-10-21 | -3.67 |
| 2024-10-18 | -3.76 |
| 2024-10-17 | -3.78 |
| 2024-10-16 | -3.79 |
| 2024-10-15 | -3.78 |
| 2024-10-14 | -3.81 |
| 2024-10-11 | -3.81 |
| 2024-10-10 | -3.79 |
| 2024-10-09 | -3.84 |
| 2024-10-08 | -3.70 |
| 2024-10-07 | -3.66 |
| 2024-10-04 | -3.75 |
| 2024-10-03 | -3.80 |
| 2024-10-02 | -3.76 |